Table 3.
Treatment | Level of Evidence | Recommendation |
---|---|---|
Hyperosmolar Therapy | Level II | Hypertonic saline acute bolus dose 6.5 – 10 ml/kg for increased ICP |
Level III | Continuous 3% saline dose 0.1 – 1.0 ml/kg/hr to maintain ICP < 20 mmHg and serum osmolarity <360 mOsm/L | |
Temperature Control | Level III | Avoid hyperthermia |
CSF Drainage | Level III | CSF drainage through an EVD may be considered. |
Barbiturates | Level III | High-dose barbiturate therapy in cases of refractory intracranial hypertension. |
Decompressive craniectomy | Level III | Consider in early signs of neurologic deterioration or herniation or are developing intracranial hypertension refractory to medical management during the early stages of treatment. |
Analgesics, sedatives, and neuromuscular blockade | Level III | Etomidate may be considered to control severe intracranial hypertension. Thiopental may be considered to control intracranial hypertension. |
Antiseizure prophylaxis | Level III | Prophylactic treatment with phenytoin may be considered to reduce the incidence of early PTS. |
ICP = intracranial pressure; CSF = cerebrospinal fluid; EVD = external ventricular device; mL = milliliter; kg = kilogram; hr = hour; PaCO2 = arterial carbon dioxide; PTS = posttraumatic seizures
Adapted from (Kochanek et al., 2012)